Prognostic models for selecting patients with acute pulmonary embolism for initial outpatient therapy

2008 ◽  
Vol 14 (5) ◽  
pp. 414-421 ◽  
Author(s):  
David Jiménez ◽  
Roger D Yusen
CHEST Journal ◽  
2007 ◽  
Vol 132 (1) ◽  
pp. 24-30 ◽  
Author(s):  
David Jiménez ◽  
Roger D. Yusen ◽  
Remedios Otero ◽  
Fernando Uresandi ◽  
Dolores Nauffal ◽  
...  

2021 ◽  
Vol 198 ◽  
pp. 40-48
Author(s):  
Antoine Elias ◽  
Jeannot Schmidt ◽  
Abdelouahab Bellou ◽  
Grégoire Le Gal ◽  
Pierre-Marie Roy ◽  
...  

BMJ Open ◽  
2016 ◽  
Vol 6 (4) ◽  
pp. e010324 ◽  
Author(s):  
Antoine Elias ◽  
Susan Mallett ◽  
Marie Daoud-Elias ◽  
Jean-Noël Poggi ◽  
Mike Clarke

2016 ◽  
Vol 43 (3) ◽  
pp. 326-332 ◽  
Author(s):  
Federico Angriman ◽  
Fernando J. Vazquez ◽  
Pierre Marie Roy ◽  
Gregoire Le Gal ◽  
Marc Carrier ◽  
...  

2018 ◽  
Vol 119 (01) ◽  
pp. 140-148 ◽  
Author(s):  
Maciej Kostrubiec ◽  
Magdalena Pływaczewska ◽  
David Jiménez ◽  
Mareike Lankeit ◽  
Michał Ciurzynski ◽  
...  

Background Haemodynamic alterations caused by acute pulmonary embolism (PE) may affect multi-organ function including kidneys. This multi-centre, multinational cohort study aimed to validate the prognostic significance of estimated glomerular filtration rate (eGFR) and its potential additive value to the current PE risk assessment algorithms. Methods The post hoc analysis of pooled prospective cohort studies: 2,845 consecutive patients (1,424 M/1,421 F, 66 ± 17 years) with confirmed acute PE and followed up for 180 days. We tested prognostic value of pre-specified eGFR level ≤60 mL/min/1.73 m2 calculated on admission according to the Modification of Diet in Renal Disease study equation. The primary outcome was all-cause 30-day mortality; the secondary outcomes were PE-related mortality, 180-day all-cause mortality, bleeding and composite outcome (PE-related death, thrombolysis or embolectomy). Results Two hundred and twenty-three patients (8%; 95% confidence interval [CI]: 7–9%) died within the first 30 days after the diagnosis. The eGFR on admission was significantly lower in non-survivors than in survivors (64 ± 34 vs. 75 ± 3 mL/min/1.73 m2, p < 0.0001). Independent predictors for a fatal outcome included: cancer, systolic blood pressure, older age, hypoxia, eGFR, heart rate and coronary artery disease. The eGFR of ≤60 mL/min/1.73 m2 independently predicted all-cause mortality (hazard ratio: 2.3; 95% CI: 1.7–3.0, p < 0.0001), PE-related outcome and clinically relevant bleedings (odds ratio: 0.90 per 10 mL/min/1.73 m2, 95% CI: 0.85–0.95, p = 0.0002). The eGFR assessment significantly improved prognostic models proposed by European guidelines with net re-classification improvement of 0.42 (p < 0.0001). Conclusion The eGFR of ≤60 mL/min/1.73 m2 not only independently predicted higher 30- and 180-day all-cause mortality and bleeding events, but when added to the current European Society of Cardiology risk stratification algorithm improved identification of both low- and high-risk patients. Therefore, eGFR calculation should be implemented in the risk assessment of acute PE.


2016 ◽  
Vol 65 (4) ◽  
pp. 771-779
Author(s):  
Abd-ElRahim Ibrahim Youssef ◽  
Hanan Mohamed ElShahat ◽  
Amany Shaker Radwan ◽  
Maha El-Sayed Al-Sadek

VASA ◽  
2014 ◽  
Vol 43 (6) ◽  
pp. 450-458 ◽  
Author(s):  
Julio Flores ◽  
Ángel García-Avello ◽  
Esther Alonso ◽  
Antonio Ruíz ◽  
Olga Navarrete ◽  
...  

Background: We evaluated the diagnostic efficacy of tissue plasminogen activator (tPA), using an enzyme-linked immunosorbent assay (ELISA) and compared it with an ELISA D-dimer (VIDAS D-dimer) in acute pulmonary embolism (PE). Patients and methods: We studied 127 consecutive outpatients with clinically suspected PE. The diagnosis of PE was based on a clinical probability pretest for PE and a strict protocol of imaging studies. A plasma sample to measure the levels of tPA and D-dimer was obtained at enrollment. Diagnostic accuracy for tPA and D-dimer was determined by the area under the receiver operating characteristic (ROC) curve. Sensitivity, specificity, predictive values, and the diagnostic utility of tPA with a cutoff of 8.5 ng/mL and D-dimer with a cutoff of 500 ng/mL, were calculated for PE diagnosis. Results: PE was confirmed in 41 patients (32 %). Areas under ROC curves were 0.86 for D-dimer and 0.71 for tPA. The sensitivity/negative predictive value for D-dimer using a cutoff of 500 ng/mL, and tPA using a cutoff of 8.5 ng/mL, were 95 % (95 % CI, 88–100 %)/95 % (95 % CI, 88–100 %) and 95 % (95 % CI, 88–100 %)/94 %), respectively. The diagnostic utility to exclude PE was 28.3 % (95 % CI, 21–37 %) for D-dimer and 24.4 % (95 % CI, 17–33 %) for tPA. Conclusions: The tPA with a cutoff of 8.5 ng/mL has a high sensitivity and negative predictive value for exclusion of PE, similar to those observed for the VIDAS D-dimer with a cutoff of 500 ng/mL, although the diagnostic utility was slightly higher for the D-dimer.


Sign in / Sign up

Export Citation Format

Share Document